can you take dpp4 and glp 1 together Potential mechanisms of action of dipeptidyl peptidase 4 on bone GLP-1 Series Part 1: Utilization

GLP-1 receptor agonists (like semaglutide/Ozempic) and dual GLP-1/GIP agonists (like tirzepatide/Mounjaro) were originally developed to treat type 2 diabetes

Additionally, it has been hypothesized that this peptide may impact the signaling networks involved in tissue maintenance and regeneration

However, the potential of ghrelin and GLP-1 to modulate reward responses in humans has not been systematically reviewed before

Beyond those subsets, he says the drug will limit progression for those not taking insulin yet and help those on a limited dose to get off insulin.

A typical schedule for a patient at the 2.4 mg maintenance dose looks like this: Weeks 1 to 4: reduce to 1.7 mg weekly Weeks 5 to 8: reduce to 1.0 mg weekly Weeks 9 to 12: reduce to 0.5 mg weekly Weeks 13 to 16: reduce to 0.25 mg weekly Week 17: discontinue, or hold at 0.25 mg as a low-dose maintenance strategy if tolerated Patients using Ozempic (semaglutide 0.5 to 2.0 mg) for type 2 diabetes follow a similar reversal of the 0.25 mg to 0.5 mg to 1.0 mg to 2.0 mg escalation ladder